LLY

NYSE

ELI LILLY & Co

Latest disclosureSeptember 22, 2026

Insider score Why 0?: 0/ 100
Qualifying buys · 30d: $0

0 purchases · 6 sales

Price by TradingView

Insider transactions 37

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

Sale disclosed

Patrik Jonsson

EVP & President, LLY Int'l

Common Stock

Reported value: $7.64M
Reported price: $1,175.10 / share

Sale disclosed

Donald A. Zakrowski

SVP, Finance, & CAO

Common Stock

Reported value: $2.37M
Reported price: $1,185.01 / share

Sale disclosed

Anat Hakim

EVP, GC & Secretary

Common Stock

Reported value: $5.95M
Reported price: $1,190.00 / share

Sale disclosed

Ilya Yuffa

EVP&Pres, LLY USA&Global Capab

Common Stock

Reported value: $2.88M
Reported price: $1,150.77 / share

Sale disclosed

Endowment Lilly

Other reporting owner

Common Stock

Reported value: $13.55M
Reported price: $995.225 / share

Sale disclosed

Endowment Lilly

Other reporting owner

Common Stock

Reported value: $2.2M
Reported price: $996.183 / share

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
EVP & President, LLY Int'l	Common StockSale10b5-1	6,500$1,175.10 / share	$7.64M	Aug 17Filed Aug 18 · 1d later	SEC filing
SVP, Finance, & CAO	Common StockSale10b5-1	2,000$1,185.01 / share	$2.37M	Aug 10Filed Aug 11 · 1d later	SEC filing
EVP, GC & Secretary	Common StockSale10b5-1	5,000$1,190.00 / share	$5.95M	Aug 7Filed Aug 10 · 3d later	SEC filing
EVP&Pres, LLY USA&Global Capab	Common StockSale10b5-1	2,500$1,150.77 / share	$2.88M	Jun 10Filed Jun 11 · 1d later	SEC filing
Other reporting owner	Common StockSale2 trades	15,828avg $995.36 / share	$15.75M	May 6Filed May 7 · 1d later	2 filings 13,620 @ $995.23 · $13.55MSEC filing 2,208 @ $996.18 · $2.2MSEC filing

Congress transactions 26

All Congress filings

Partial sale disclosedAmended report

Eli Lilly and Company · Stock

The filing reports a partial sale for a joint account.

John BoozmanReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 21, 2025

Sale disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a sale for the member.

Michael RulliReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: July 1, 2026

Purchase disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a purchase for the member.

Michael RulliReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: January 2, 2026

Sale disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a sale for the member.

Michael RulliReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 2, 2025

Full sale disclosedAmended report

Eli Lilly and Company · Stock

The filing reports a full sale for a joint account.

Thomas H TubervilleReporting Senate member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: April 15, 2025

Full sale disclosed

Eli Lilly and Company Common Stock · Stock

The filing reports a full sale for the member.

AAAlan ArmstrongReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 27, 2026

Partial sale disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a partial sale for a spouse.

Dan NewhouseReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: July 10, 2026

Purchase disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $50,001 – $100,000Reported range; exact amount not disclosed.
Trade date: June 10, 2026

Purchase disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a purchase for a spouse.

Byron DonaldsReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: April 2, 2026

Purchase disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a purchase for the member.

Byron DonaldsReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: April 2, 2026

Purchase disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: April 14, 2026

Partial sale disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a partial sale for the member.

Elizabeth FletcherReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: April 8, 2026

Partial sale disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a partial sale for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 13, 2026

Full sale disclosed

Eli Lilly and Company Common Stock · Stock

The filing reports a full sale for a spouse.

Angus S King Jr.Reporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: February 13, 2026

Purchase disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a purchase for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: February 26, 2026

Sale disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a sale for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: February 9, 2026

Sale disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a sale for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: January 16, 2026

Purchase disclosed

Eli Lilly and Company · Stock

The filing reports a purchase for a spouse.

Angus S King Jr.Reporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 29, 2025

Purchase disclosed

Eli Lilly and Company Common Stock · Stock

The filing reports a purchase for a joint account.

Markwayne MullinReporting Senate member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: December 29, 2025

Sale disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a sale for a joint account.

Julie JohnsonReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 18, 2025

Sale disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a sale for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 10, 2025

Purchase disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 18, 2025

Partial sale disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a partial sale for a joint account.

Julie JohnsonReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 13, 2025

Partial sale disclosed

Eli Lilly and Company · Stock

The filing reports a partial sale for a joint account.

John BoozmanReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 21, 2025

Purchase disclosed

Eli Lilly and Company · Stock

The filing reports a purchase for a spouse.

Shelley M CapitoReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 24, 2025

Showing the latest 25 of 26 disclosed trades. Show all 26 trades

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000059478
Latest public acceptance: Sep 22, 2026, 08:15 PM UTC
Score calculated: Oct 7, 2026, 12:04 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Reporting insider

Security / transaction

Amount / price

Value

Traded / disclosed

Source

EVP & President, LLY Int'l

Common StockSale10b5-1

6,500$1,175.10 / share

$7.64M

Aug 17Filed Aug 18 · 1d later

SEC filing

SVP, Finance, & CAO

Common StockSale10b5-1

2,000$1,185.01 / share

$2.37M

Aug 10Filed Aug 11 · 1d later

SEC filing

EVP, GC & Secretary

Common StockSale10b5-1

5,000$1,190.00 / share

$5.95M

Aug 7Filed Aug 10 · 3d later

SEC filing

EVP&Pres, LLY USA&Global Capab

Common StockSale10b5-1

2,500$1,150.77 / share

$2.88M

Jun 10Filed Jun 11 · 1d later

SEC filing

Other reporting owner

Common StockSale2 trades

15,828avg $995.36 / share

$15.75M

May 6Filed May 7 · 1d later

2 filings

13,620 @ $995.23 · $13.55MSEC filing
2,208 @ $996.18 · $2.2MSEC filing

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000059478
Latest public acceptance: Sep 22, 2026, 08:15 PM UTC
Score calculated: Oct 7, 2026, 12:04 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.